Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Mar 12:rs.3.rs-3929981.
doi: 10.21203/rs.3.rs-3929981/v1.

State-dependent central synaptic regulation by GLP-1 is essential for energy homeostasis

Affiliations

State-dependent central synaptic regulation by GLP-1 is essential for energy homeostasis

Le Wang et al. Res Sq. .

Update in

Abstract

Central nervous system (CNS) control of metabolism plays a pivotal role in maintaining energy homeostasis. Glucagon-like peptide-1 (GLP-1, encoded by Gcg), secreted by a distinct population of neurons located within the nucleus tractus solitarius (NTS), suppresses feeding through projections to multiple brain targets1-3. Although GLP-1 analogs are proven clinically effective in treating type 2 diabetes and obesity4, the mechanisms of GLP-1 action within the brain remain unclear. Here, we investigate the involvement of GLP-1 receptor (GLP-1R) mediated signaling in a descending circuit formed by GLP-1R neurons in the paraventricular hypothalamic nucleus (PVNGLP-1R) that project to dorsal vagal complex (DVC) neurons of the brain stem in mice. PVNGLP- 1R→DVC synapses release glutamate that is augmented by GLP-1 via a presynaptic mechanism. Chemogenetic activation of PVNGLP-1R→DVC neurons suppresses feeding. The PVNGLP-1R→DVC synaptic transmission is dynamically regulated by energy states. In a state of energy deficit, synaptic strength is weaker but is more profoundly augmented by GLP-1R signaling compared to an energy-replete state. In an obese state, the dynamic synaptic strength changes in the PVNGLP-1R→DVC descending circuit are disrupted. Blocking PVNGLP-1R→DVC synaptic release or ablation of GLP-1R in the presynaptic compartment increases food intake and causes obesity, elevated blood glucose, and impaired insulin sensitivity. These findings suggest that the state-dependent synaptic plasticity in this PVNGLP-1R→DVC descending circuit mediated by GLP-1R signaling is an essential regulator of energy homeostasis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interests The authors declare no conflict of interest.

Figures

Figure 1:
Figure 1:. PVNGLP-1R→DVC descending circuit is regulated by GLP-1R-mediated signaling.
a. Experimental paradigm for AAV-DIO-ChR2-EYFP injection to label PVN GLP-1R neurons. b. Representative image of the PVN with AAV-mediated expression of ChR2-EYFP. c-d. Representative image of DVC with expression of ChR2-EYFP. e. DVC cells were patched and evaluated for synaptic connectivity with optogenetically evoked EPSCs (oEPSCs) that are blocked by CNQX (n=20 cells/12 mice). f. Percentage of neurons showing synaptic connections (numbers indicate the numbers of responsive cells/total cells). g-h. Representative traces and quantification of AMPAR mediated oEPSCs before and after application of Exn-4 (n=29 cells/12 mice). i-j. Representative traces and quantification of light-evoked PPR before and after application of Exn-4 (n=24 cells/12 mice). k. Representative traces of oEPSCs with or without Exn-4. AMPAR- and NMDAR-mediated oEPSCs were recorded at holding potentials of −70 mV and +60 mV, respectively. NMDAR- oEPSCs were measured at 50 ms after stimulations. l. Pooled data of AMPAR/NMDAR-EPSCs ratio before and after application of Exn-4 (n=15 cells/12 mice). m-n. Representative traces and quantification of AMPAR-mediated oEPSCs before and after application of H89 and Exn-4 (n=10 cells/3 mice). Data are presented as mean ± SEM and sample sizes are indicated in each plot; paired student’s t-tests are applied to (e) and (g-n). One-way ANOVA is applied to (f); ∗p< 0.05; ∗∗p< 0.01; ∗∗∗p< 0.001; ∗∗∗∗p< 0.0001.
Figure 2:
Figure 2:. State-dependent PVNGLP-1R→DVC neuronal activity suppresses feeding.
a. Experimental paradigm for virus delivery and chemogenetic stimulation of PVNGLP-1RDVC neurons. b. Representative image of AAV-fDIO-hM3Dq-mCherry expression in the PVNGLP-1R→DVC neurons. c. Representative traces of CNO application. d. Quantification of CNO application in PVN hM3Dq- or control-virus expressing cells (n=6 cells/2 mice). e. Food intake consumption upon activation of PVNGLP-1RDVC neurons in the dark cycle (control n=9 mice, hM3Dq n=7 mice). f. Experimental paradigm for virus delivery and fiber photometry imaging of PVNGLP-1RDVC neurons. G. Representative image of Gcamp6f expression in the PVNGLP-1RDVC neurons. h. Representative traces of PVNGLP-1RDVC neuron’s calcium activity in the fasted and fed state. i. Frequency and amplitude quantification of PVNGLP-1RDVC neurons’ calcium activity in the fast and fed state (n=20 trial/5 mice). j-k. Calcium signals of PVNGLP-1RDVC neurons during different food/object presentations and under different energy states (n=5 mice). Data are presented as mean ± SEM and sample sizes are indicated in each plot; paired student’s t-test is applied to (d) and (i); One-way ANOVA is applied to (k). Two-way ANOVA with Geisser-Greenhouse correction is applied to (e). *p< 0.05; **p<0.01.
Figure 3:
Figure 3:. State-dependent synaptic plasticity of PVNGLP-1R→DVC neurons.
a-b. Experimental paradigm for AAV-DIO-Chr2-EYFP injection and electrophysiology experiments. c-f. Representative traces and quantification of AMPAR-mediated oEPSCs (Fed n=21 cells/3 mice, Fasted n=30 cells/4 mice), NMDAR EPSCs (Fed n=21 cells/3 mice, Fasted n=29 cells/4 mice), and AMPAR/NMDAR EPSC ratio (Fed n=21 cells /3 mice, Fasted n=29 cells/4 mice) under different conditions. g-i. Representative traces and quantification of AMPAR oEPSCs witho or without Exn-4 under different energy states (Fed n=11 cells/4 mice, Fasted n=10 cells/3 mice). j-k. Representative traces and quantification of normalized AMPAR-mediated oEPSCs with or without Exn-4 under different energy states (Fed n=11 cells/4 mice, Fasted n=10 cells/3 mice). Data are presented as mean ± SEM and n numbers are indicated in each plot. Student’s t-tests are applied to (d-f) and (k), and paired student’s t-tests are applied to (h) and (i). *p< 0.05; **p<0.01, ***p<0.001.
Figure 4:
Figure 4:. High-fat diet (HFD) induced obesity blunts the state-dependent synaptic plasticity of PVNGLP-1R→DVC neurons.
a-b. Experimental paradigm for AAV-DIO-Chr2-EYFP injection and electrophysiology experiments. c-f. Representative traces and quantification of AMPAR-mediated oEPSCs (Control n=25 cells/3 mice, HFD n=23 cells/3 mice), NMDAR-oEPSCs (Control n=25 cells/3 mice, HFD n=21 cells/3 mice), and AMPAR/NMDAR EPSC ratio (Control n=25 cells/3 mice, HFD n=21 cells/3 mice) in control or HFD animal. g-i. Representative traces and quantification of AMPAR oEPSCs (Fed n=19 cells/3 mice, Fasted n=19 cells/3 mice), NMDAR oEPSCs (Fed n=18 cells/3 mice, Fasted n=18 cells/3 mice), and AMPAR/NMDAR EPSCs ratio (Fed n=18 cells/3 mice, Fasted n=18 cells/3 mice) under different energy states in HFD-induced obese animals. k-l. Representative traces and quantification of AMPAR-mediated oEPSCs before and after application of Exn-4 in HFD-induced obese animals (n=8 cells/7 mice). m-n. Representative traces and quantification of AMPAR-mediated oEPSCs after control or Liraglutide i.p. 2h injection (control n=19 cells/3 mice, Liraglutide n=25 cells/3 mice) in HFD obese mice. Data are presented as mean ± SEM and sample sizes are indicated in each plot; Student’s t-tests are applied to (d-j) and (n), and paired student’s t-tests are applied to (l). *p< 0.05; **p<0.01, ***p<0.001, ***p<0.0001.
Figure 5:
Figure 5:. Chronic perturbation of PVNGLP-1R→DVC neurons induces obesity.
a. Experimental paradigm for the depletion of PVNGLP-1RDVC neurons GLP-1R using AAV-Cre virus injection. b. Quantification of body weight gain after depletion of PVNGLP-1RDVC neurons GLP-1R (Control n=9 mice, Knockout n=12 mice). c. Quantification of daily food intake after GLP-1R ablation in PVNGLP-1RDVC neurons compared to control animals (Control n=4 mice, Knockout n=8 mice). d. Experimental paradigm for the chronic inactivation of PVNGLP-1RDVC neurons synaptic release. e. Representative image of the PVN showing the expression of TeNT-GFP in the PVNGLP-1RDVC neurons. f. Quantification of body weight gain after expressing TeNT/Control in PVNGLP-1RDVC neurons (Control n= 7–8 mice, TeNT n=9 mice). g. Quantification of daily food intake after expressing TeNT in PVNGLP-1RDVC neurons as compared to control animals (control n=8 mice, TeNT n=9 mice). h. Fasting glucose levels (Control n=7 mice, TeNT n=9 mice). i. Insulin tolerance test-induced glucose level changes (Control n=7 mice, TeNT n=9 mice). j-m Liver, subcutaneous WAT, perigonadal WAT, and BAT weight in TeNT-injected and control animals (Control n=6 mice, TeNT n=9 mice). Data are presented as mean ± SEM and sample sizes are indicated in each plot. Two-way ANOVA, with Geisser-Greenhouse correction, is applied to (b), (f), and (i); Student’s t-tests are applied to (c), (g-h), and (j-m). *p< 0.05; **p<0.01, ***p<0.001, ***p<0.0001.

References

    1. Sandoval D. CNS GLP-1 regulation of peripheral glucose homeostasis. Physiol Behav 94, 670–674 (2008). 10.1016/j.physbeh.2008.04.018 - DOI - PMC - PubMed
    1. Morton G. J., Cummings D. E., Baskin D. G., Barsh G. S. & Schwartz M. W. Central nervous system control of food intake and body weight. Nature 443, 289–295 (2006). 10.1038/nature05026 - DOI - PubMed
    1. Ly T. et al. Sequential appetite suppression by oral and visceral feedback to the brainstem. Nature 624, 130–137 (2023). 10.1038/s41586-023-06758-2 - DOI - PMC - PubMed
    1. Drucker D. J. GLP-1 physiology informs the pharmacotherapy of obesity. Mol Metab 57, 101351 (2022). 10.1016/j.molmet.2021.101351 - DOI - PMC - PubMed
    1. Zhang C. et al. Area Postrema Cell Types that Mediate Nausea-Associated Behaviors. Neuron 109, 461–472 e465 (2021). 10.1016/j.neuron.2020.11.010 - DOI - PMC - PubMed

Publication types